🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#LiverX The Baveno Cooperation: an EASL Consortium #PortalHypertension 🥇Carvedilol vs. 🥈propranolol for the prevention of decompensation and mortality in patients with #cACLD and decompensated #cirrhosis 📕 Study Journal of Hepatology EASLnews 🔗journal-of-hepatology.eu/article/S0168-…

📌Breakthroughs Beyond the Journal by David Trampert Gut bacterial membrane components as pathogenic signalling molecules in PSC-IBD Full text here👉doi.org/10.1016/j.jhep… Refers to👉doi.org/10.1053/j.gast…

👏We extend our sincere gratitude to Paolo Angeli for his significant contributions to the Journal of Hepatology Watch this video where he shares insights from his tenure as Editor-in-Chief: 🎬youtube.com/watch?v=yzAErv… #LiverTwitter EASLnews EASL Education

Today’s #readoftheweek📚highlights the significant variability of virologic responses to NA therapy in patients with #ChronicHepatitisB. Read here this JHEP Reports article: jhep-reports.eu/article/S2589-… 🙏@pippa_matt Tina Wang Ellie Barnes 🚵‍♀️ et al. #LiverTwitter #LiverX

📢Adolescent sobriety under siege ➡️An urgent call to protect children from alcohol harms ➡️EASL calls on all countries to establish and enact comprehensive strategies to mitigate alcohol-related harms 🔗journal-of-hepatology.eu/article/S0168-… #LiverTwitter EASLnews EASL Education EASL Advocacy

📌In our March issue Dysglycemia and liver lipid content determine the relationship of insulin resistance with hepatic OXPHOS capacity in obesity #OpenAccess here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

📌In our March issue Decreases in cT1 and liver fat content reflect treatment-induced histological improvements in MASH #OpenAccess here: journal-of-hepatology.eu/article/S0168-… #LiverTwitter

📌In our March issue Predictors of hepatic flares after nucleos(t)ide analogue cessation – Results of a global cohort study (RETRACT-B study) #OpenAccess here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

🆕Article in press❕ A phase IIb randomised-controlled trial of the FFAR1/FFAR4 agonist icosabutate in MASH Full text here👉bit.ly/4iucrzV More information here👉bwnews.pr/4hadNie #OpenAccess #LiverTwitter

📌In our March issue Regulation of KIF23 by miR-107 controls replicative tumor cell fitness in mouse and human hepatocellular carcinoma #OpenAccess here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

📌In our March issue Hepatocyte aquaporin 8-mediated water transport facilitates bile dilution and prevents gallstone formation in mice Read it here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

📌In our March issue Assessment of liver graft quality during hypothermic oxygenated perfusion: The first international validation study Read it here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

📌In our March issue Non-invasive assessment of severe liver fibrosis in patients with Fontan-associated liver disease: The VALDIG-EASL FONLIVER cohort Read it here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

📌In our March issue Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study Read it here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

Is there a safe limit for consumption of alcohol❓ 📢Excessive drinking always risky Abstain from alcohol when: ➡️Chronic illness ➡️Driving a vehicle ➡️Pregnancy Less alcohol use for young adults & those with co-morbidities❗️ Full text: bit.ly/3QtfUTd #LiverTwitter

🆕CPG❕ EASL-ERN Clinical Practice Guidelines on Wilson’s disease ✅Evidence-based recommendations for hepatologists, neurologists, GPs, pediatricians & all involved in #WD care Full text here: bit.ly/42aw1vA #LiverTwitter EASLnews EASL Education ERN RARE LIVER

📌In our March issue Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases Read it here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

📌In our March issue AI-Safe-C score: Assessing liver-related event risks in patients without cirrhosis after successful direct-acting antiviral treatment Read it here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

📌In our March issue Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: A post hoc analysis of the PREDESCI trial #OpenAccess here👉 journal-of-hepatology.eu/article/S0168-… #LiverTwitter

🆕CPG❕ EASL Clinical Practice Guidelines on TIPS ✅Addresses all aspects of #TIPS in patients with #cirrhosis Full text here: bit.ly/4hZuMUK #LiverTwitter EASLnews EASL Education